Bdo Wealth Advisors, LLC Anavex Life Sciences Corp. Transaction History

Bdo Wealth Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 09, 2019	SELL	$2.75 - $3.7 $1,375 - $1,850	-500 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$1.68 - $3.42 $840 - $1,710	500 New	500 $2,000
Q4 2018 Feb 14, 2019	SELL	$1.25 - $2.75 $625 - $1,375	-500 Closed	0 $0
Q1 2018 May 23, 2018	BUY	$2.32 - $3.44 $1,160 - $1,720	500 New	500 $1,000

160

31.6M

910K

1.35M

Ticker AVXL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,942,800
Market Cap $427M
Description
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...

Get notified when there are updates to the investment portfolio of Bdo Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Bdo Wealth Advisors, LLC with notifications on news.